China:
Hotline1:13372130271
Email: sales@jshnk.com.cn
Hotline2:+86 153 7018 9178
Email:mialiu@jshnk.com.cn
Contact:Miss Liu Mia
Jiangsu headquarters telephone: +86 0512-52270007
Established in September 2020 with a registered capital of RMB 10 million and a total investment of RMB 100 million, Jiangsu Hainekon Bio-Tech Co., Ltd. (hereinafter referred to as "Hainekon" or "the Company") is a high-tech enterprise focusing on the R&D, production and sales of high quality EPA/DHA products.The manufacturing site is located in the beautiful scenery of Qiandeng ancient town which is sitting between the west of Shanghai and the east of Suzhou, a place boasting with convenient transportation domestically and internationally. The plant and production facilities will be built in two stages.The plant occupied an area of 6,300 ㎡ and some equipments will be up to running in June, and full construction will be completed by the end of 2021. With the designed manufacturing capacity for EPA/DHA in the facility of 3200 metric tons, the trial production of EPA/DHA products is planned in June 2021, and the full scale running is expected by the end 2021.
Leading by top scientists from the Omega-3 field from oversea, the R&D team in Hainekon consists of more than 20 staffs with at least college training background from various Chinese institutes. Equiped with State-Of-The-Art equipments including short-path distillation, fractional distillation, chromatography, etc, EPA/DHA products produced from this facility are of not only high purity but in a highest standard in terms of safety to human health. The application of our EPA/DHA products is from pharmaceutical intermediates to APIs to functional foods already in the market.
The quality system is fully in compliance to GMP regulation, assuring that all the product from Hainekon meet industrial standards and customer’s Specification as well.
To maintain a continuous growth, Hainekon will invest 5 to10% of annual sales revenue to build up new product pipes and next generation technologies by collaboration with a wide variety of top institutes and colleges in the world. The portifolio will cover new drugs related to Omega-3, fuctional foods, and neutraceuticals with various applications.
The company advocates the enterprise philosophy of "people-orientated, realistic and innovative" to boost its competitiveness in a longer term.With the rapidly increase of aging in China, there will be more and more demands for food and medicine derived from natural products. Hainekon will take the opportunity to grow up biger and biger in fish oil industry, and contributes a lot to the wellbeing of human health in the world.